|
Read more ›› |
By: GlobeNewswire - 22 Apr 2024
|
Related companies:
ArriVent Biopharma, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Apr 2024
|
Related companies:
OrthoPediatrics Corp. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Apr 2024
|
Related companies:
Abeona Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Apr 2024
|
Related companies:
RxSight Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Apr 2024
|
Related companies:
Akoya Biosciences, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Apr 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 22 Apr 2024
|
Related companies:
Tessera Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Apr 2024
|
Related companies:
Excision BioTherapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Apr 2024
|
Related companies:
Fate Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Apr 2024
|
Related companies:
CRISPR Therapeutics AG |
|
|
Read more ›› |
By: GlobeNewswire - 22 Apr 2024
|
Related companies:
Voyager Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Apr 2024
|
Related companies:
Kriya Therapeutics |
|
|
Read more ›› |
By: GlobeNewswire - 22 Apr 2024
|
Related companies:
Cellectis Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Apr 2024
|
Related companies:
ProQR Therapeutics NV |
|
|
Read more ›› |
By: GlobeNewswire - 22 Apr 2024
|
Related companies:
Editas Medicine, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Apr 2024
|
Related companies:
Excision BioTherapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Apr 2024
|
Related companies:
Ring Therapeutics |
|
|
Read more ›› |
By: GlobeNewswire - 22 Apr 2024
|
Related companies:
Theriva Biologics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 22 Apr 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 22 Apr 2024
|
Related companies:
TScan Therapeutics, Inc. |
|